Chinese Journal of Tissue Engineering Research ›› 2010, Vol. 14 ›› Issue (16): 2999-3002.doi: 10.3969/j.issn.1673-8225.2010.16.037

Previous Articles     Next Articles

Material features, biocompatibility of coronary artery stent and related complications following implantation

Hu Rong1, Wang Ya-li2   

  1. 1 Department of Ophthalmology, Central Hospital of Bazhong, Bazhong  636000, Sichuan Province, China; 2 Department of Cardiothoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong  637000, Sichuan Province, China
  • Online:2010-04-16 Published:2010-04-16
  • Contact: Wang Ya-li, Associate chief nurse, Department of Cardiothoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China yaliwangweiyun@163.com
  • About author:Hu Rong, Nurse-in-charge, Department of Ophthalmology, Central Hospital of Bazhong, Bazhong 636000, Sichuan Province, China 1282608494@qq.com

Abstract:

OBJECTIVE: To explore the material features and biocompatibility of coronary artery stent and related complications following implantation.
METHODS: The databases of CNKI and Medline were searched by the first author using key words of “coronary artery stent, material, biocompatibility and complications” both in English and Chinese. Meta analysis or repetitive studies were excluded, and 16 papers were included in this analysis.
RESULTS: Stent materials play an important role in reducing inflammatory reaction and restenosis following stent implantation. As a medical material for humans, the features of stent should be meet the requirements of reliable distensibility, mechanical persistence, good flexibility and geometrical stability, possible small diameter, excellent blood compatibility, as well as good corrosion resistance. All of these depended on the mechanical and physical features of materials.
CONCLUSION: The study of drug-coating stent and drug-eluting stent reduced the restenosis rates following implantation, and the biodegradable stent also attracted more attention. When treating coronary heart disease with cardiovascular stent, the complications should be avoided except consideration of the successful rate of reperfusion.

CLC Number: